Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to compare the short-term and long-term efficacies and the safeties of pirarubicin plus docetaxel(AT group) and pirarubicin plus cyclophosphamide followed by docetaxel(AC-T group) in neoadjuvant chemotherapy of breast cancer.
Epistemonikos ID: acdc4519c596c05a8d77249424b0083f28219ef3
First added on: May 12, 2024